Results 11 to 20 of about 128,736 (321)

Hyperthyroidism.

Gland Surgery, 2020
Hyperthyroidism is a condition where the thyroid gland produces and secretes inappropriately high amounts of thyroid hormone which can lead to thyrotoxicosis. The prevalence of hyperthyroidism in the United States is approximately 1.2%.
Amanda R. Doubleday, R. Sippel
semanticscholar   +3 more sources

Hyperthyroidism [PDF]

Lancet, The, 2016
Hyperthyroidism is characterised by increased thyroid hormone synthesis and secretion from the thyroid gland, whereas thyrotoxicosis refers to the clinical syndrome of excess circulating thyroid hormones, irrespective of the source. The most common cause of hyperthyroidism is Graves' disease, followed by toxic nodular goitre.
Simone De Leo, Sun Y Lee, Lewis E Braverman   +2 more
exaly   +4 more sources

Predicting the Risk of Recurrence Before the Start of Antithyroid Drug Therapy in Patients With Graves' Hyperthyroidism

Journal of Clinical Endocrinology and Metabolism, 2016
Erik Endert, Aeilko H Zwinderman
exaly   +2 more sources

Clinical outcomes of atrial fibrillation with hyperthyroidism

Journal of Arrhythmia, 2021
Background Atrial fibrillation (Afib) is a common cardiac manifestation of hyperthyroidism. The data regarding outcomes of Afib with and without hyperthyroidism are lacking.
Muhammad Zubair Khan, Ashwani Gupta, Jordesha Hodge, Kirtenkumar Patel, Krunalkumar Patel, Muhammad Samsoor Zarak, Sona Franklin, Harsh Patel, Shruti Jesani, Sejal Savani, Vraj Shah, Vincent M. Figueredo, Arvind R. Cavale, Steven Kutalek   +13 more
doaj   +1 more source

Systemic lupus erythematosus is causally associated with hypothyroidism, but not hyperthyroidism: A Mendelian randomization study

Frontiers in Immunology, 2023
Background The relationship between systemic lupus erythematosus (SLE) and thyroid diseases is still controversial. Due to confounders and reverse causation, previous studies were not convincing.
Qiong Qin, Ling Zhao, A. Ren, Wei Li, R. Ma, Qiu-ping Peng, Shiqiao Luo   +6 more
semanticscholar   +1 more source

Epidemiology of Hypothyroidism, Hyperthyroidism and Positive Thyroid Antibodies in the Croatian Population

Biology, 2022
Simple Summary The aim of this paper was to analyse the prevalence of hypothyroidism and hyperthyroidism in the Croatian population. This is the first epidemiological study of its kind conducted in our population.
Ivana Strikić Đula, Nikolina Pleić, Mirjana Babić Leko, I. Gunjača, V. Torlak, Dubravka Brdar, A. Punda, O. Polašek, C. Hayward, T. Zemunik   +9 more
semanticscholar   +1 more source

Hyperthyroidism with papillary thyroid carcinoma in HIV: Case report and literature review

Heliyon, 2023
The immune function of HIV infected patients is severely damaged, which can cause a series of autoimmune related diseases including hyperthyroidism. Hyperthyroidism includes both primary and secondary hyperthyroidism.
Yang yang Guan
doaj   +1 more source

Ameliorative Effect of Ghrelin on Thyroxin Hormones and Body Weight in Hyperthyroidism Male rats [PDF]

Basrah Journal of Veterinary Research, 2021
The study's objective is to evaluate the enhanced effect of the ghrelin on the body weight and thyroid hormones in male rats after inducing hyperthyroidism by L–thyroxin. The rats (95 males) were split into two groups.
Fouad Hamza, Muna AL-Saeed
doaj   +1 more source

Causal relationship between rheumatoid arthritis and hypothyroidism or hyperthyroidism: a bidirectional two-sample univariable and multivariable Mendelian randomization study

Frontiers in Endocrinology, 2023
ObjectiveThe causal relationship between Rheumatoid arthritis (RA) and hypothyroidism/hyperthyroidism remains controversial due to the limitations of conventional observational research, such as confounding variables and reverse causality.
Rui Lai, Xinmin Deng, Xiaofeng Lv, Qian Liu, Kun Zhou, Dezhong Peng   +5 more
doaj   +1 more source

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

Hepatology, EarlyView., 2022
Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou, Yongkun Sun, Wen Zhang, Jiajia Yuan, Zhi Peng, Wei Wang, Jifang Gong, Lin Yang, Yanshuo Cao, Hong Zhao, Chao Chen, Weifeng Wang, Lin Shen, Aiping Zhou   +13 more
wiley   +1 more source